California Pacific Medical Center
Industry / private company
Location:
San Francisco, CA,
United States (USA) (US)
ISNI: 0000000098234542
ROR: https://ror.org/02bjh0167
Show on Map:
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma. (2022)
Schuler M, Zimmer L, Kim KB, Sosman JA, Ascierto PA, Postow MA, De Vos FY, et al.
Journal article
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases (2020)
Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer A, Vetter M, et al.
Journal article
International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease (2018)
Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, et al.
Conference contribution